In addition to recurrent DNA mutations and epigenetic deregulation9, RNA editing mediated by cytokine-responsive ADAR1 has emerged as a vital contributor to transcriptome remodeling leading to cancer relapse and progression7,10–12, however the contribution of pro-inflammatory signaling leading to ADAR1-dependent RNA editing in MM pathogenesis has not been previously explored. This evidence concerns the gene ADAR and cancer.